Centrilobular Fibrosis: An Underrecognized Pattern in Systemic Sclerosis


Autoria(s): SOUZA, Romy B. C. de; BORGES, Claudia T. L.; CAPELOZZI, Vera L.; PARRA, Edwin R.; JATENE, Fabio B.; KAVAKAMA, Jorge; KAIRALLA, Ronaldo A.; BONFA, Eloisa
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

Background: The impressive association of lung involvement and gastroesophageal reflux in scleroderma raises the possibility of a cause-effect relationship. Objectives: To determine clinical, radiological and histopathological features of systemic sclerosis (SSc) patients according the presence or absence of centrilobular fibrosis (CLF). Methods: Twenty-eight SSc patients with lung involvement were submitted to open lung biopsy and the specimens classified for the presence of CLF (bronchocentric distribution of the lesions and intraluminal matter according to the classification of idiopathic interstitial pneumonia). HRCT, pulmonary function tests and esophageal analysis were also performed. Subsequently, cyclophosphamide was introduced for the nonspecific interstitial pneumonia subgroup and antireflux treatment was intensified for isolated CLF patients. Results: Isolated CLF was found in 21% of the biopsies and also found associated to nonspecific interstitial pneumonia in 84% of these patients. The other 3 cases had usual interstitial pneumonia, pulmonary hypertension and respiratory bronchiolitis-associated interstitial lung disease. The histopathological analysis revealed that all 6 patients with isolated CLF had the bronchocentric distribution and intraluminal basophilic content, with foreign bodies detected in one third of them. The central distribution of lung involvement on HRCT was found in 67% of these patients with a consistent patchy distribution (100%). Ground glass (67%) and consolidation (33%) were the predominant patterns found. The constant clinical finding in all isolated CLF cases was dyspnea, esophageal abnormalities and a moderate lung impairment (FVC: 63.83 +/- 16.31%; DLCO: 61.66 +/- 18.84%). Lung function parameters in isolated CLF patients remained stable after 1 year of exclusively intensive antireflux treatment (FVC, p = 0.23; DLCO, p = 0.59). Conclusions: The novel description of CLF pattern in SSc lung disease with peculiar histological, tomographic and clinical features will certainly contribute to a more appropriate therapeutic approach. Copyright (C) 2008 S. Karger AG, Basel

CNPQ[305468/20065]

CNPQ[301576/2004-1]

Frederico Foundation

FAPESP[2007/53982-4]

Identificador

RESPIRATION, v.77, n.4, p.389-397, 2009

0025-7931

http://producao.usp.br/handle/BDPI/21615

10.1159/000156958

http://dx.doi.org/10.1159/000156958

Idioma(s)

eng

Publicador

KARGER

Relação

Respiration

Direitos

restrictedAccess

Copyright KARGER

Palavras-Chave #Centrilobular fibrosis #Foreign bodies #Gastroesophageal reflux #Interstitial lung disease #Systemic sclerosis #Treatment #IDIOPATHIC PULMONARY-FIBROSIS #NONSPECIFIC INTERSTITIAL PNEUMONIA #ACID GASTROESOPHAGEAL-REFLUX #CHRONIC OCCULT ASPIRATION #LUNG-DISEASE #SCLERODERMA #INVOLVEMENT #PREVALENCE #ASTHMA #ALVEOLITIS #Respiratory System
Tipo

article

original article

publishedVersion